Addressing the Global Threat of Antimicrobial Resistance (AMR)

Share this article:

Download PDF
As the world's largest manufacturer of antibiotics, Teva is committed to working with industry peers and global health organizations to identify solutions. Our approach to addressing AMR focuses on: Research and science, access, appropriate use, environment

NPS-ALL-NP-00726  November 2022

Find out more

You might also be interested



3 Trends I’m Watching in Clinical Research Studies

on the meeting

Why Diversity in Clinical Trials is So Important


Living With an Invisible Disability: What We All Need to Know

little boys hugging smiling

Spreading HOPE: Teva’s Work to Improve Global Access to Medicine

Medical specialists at work, consulting with the goal of improving patient safety.

Medical Specialists We All Need but Never See: Safety Physicians

Teva employees outdoors discuss sustainability

3 Trends I’m Watching in Sustainability


What are the 3 biggest elements shaping clinical development today?

Teva Employees Meeting in Office

Teva Named One of the World’s Most Sustainable Companies

Eric Hughes, Chief Medical Officer giving a speech

How Can We Use AI to Make Medicines More Efficiently?

Teva Employees outdoors in West Chester US

Going Green for Greater Health